Print

Lay Description

The goal of the Molecular Transducers of Physical Activity Consortium (MoTrPAC) is to assess molecular changes that occur in response to physical activity (PA). To achieve this aim, a mechanistic randomized controlled trial (RCT) is conducted, in which adult study participants are randomized to endurance exercise (EE) training, resistance exercise (RE) training, or no exercise Control for a period of approximately 12 weeks. The overarching hypothesis is that there are discoverable molecular transducers that communicate and coordinate the effects of exercise on cells, tissues, and organs, which may initiate processes ultimately leading to the health benefits of exercise. Because this is a mechanistic trial, the main goal is not a health-related outcome. Rather, the goal is to generate a map of the molecular responses to exercise that will be used by the Consortium and by the scientific community at large to generate hypotheses for future investigations of the health benefits of PA.

Category

  • Healthy Subjects Needed
  • Exercise
IRB Number
20190077HU
NCT Number
NCT03960827
Open to Enrollment
Yes

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups

Study Contact


Tiffany Cortes
(210) 450-8998
cortest@uthscsa.edu

Sandra Idar
(210) 450-0568
idars@uthscsa.edu

Blake Rasmussen
(210) 567-0000
rasmussenb@uthscsa.edu

Sandra Idar
(210) 450-0568
idars@uthscsa.edu

Blake Rasmussen
(210) 567-0000
rasmussenb@uthscsa.edu

Principal Investigator
Blake Rasmussen